Barclays analyst Benjamin Theurer lowered the firm’s price target on Corteva to $67 from $70 and keeps an Overweight rating on the shares. The analyst still believes Corteva is well positioned to further drive earnings growth, saying its margin expansion trajectory remains intact on the back of portfolio optimization and lower net royalty payments in subsequent years.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CTVA:
- 3 Best Stocks to Buy Now, 8/14/2023, According to Top Analysts
- DuPont, Corteva, state AGs agree to revise PFAS settlement terms, Bloomberg says
- Corteva price target lowered to $72 from $74 at Mizuho
- Corteva lowers FY23 operating EPS view to $2.75-$2.90 from $2.80-$3.00
- Corteva Reports Second Quarter and First Half 2023 Results, Updates Full-Year Net Sales and Earnings Guidance